BioSpace News Archive

BioSyent Inc. released its financial results for the three and twelve months ended December 31, 2021.

Transcenta Holding Limited (“Transcenta”) (HKEX: 06628), announces that Transcenta has presented the safety/tolerability and preliminary anti-tumor activity data in gastric and pancreatic cancers of TST001 China phase I clinical trial as a poster presentation at the 2022 International Gastric Cancer Congress (IGCC).

Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response (DDR) technologies, is pleased to announce the acceptance of a new abstract to be presented at the 2022 AACR Annual Meeting.

electroCore, Inc., a commercial-stage bioelectronic medicine company, announced the appointment of Julie Bruzzone Goldstein and Tricia Wilber to the company’s Board of Directors effective March 15, 2022.

Saliva may hold the key to understanding and ultimately treating gastrointestinal (GI) disturbance in children with autism spectrum disorder (ASD). A recently published paper showed that specific RNA molecules in the saliva may serve as biomarkers for better understanding the etiology of GI disturbance and eventually guide targeted treatments.

Sheppard, Mullin, Richter & Hampton LLP is pleased to announce that a five-person team, led by partner Scott S. Liebman, has joined the firm’s Life Sciences and FDA Regulatory industry teams.

The rise in healthcare awareness and prevalence of chronic diseases has increased the demand for neuroprosthetic devices and implants.

Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, announced today that it has been awarded a $1.7 Million Small Business Innovation Research (SBIR) Phase II grant from the National Institute of General Medical Sciences.

Published online March 9 in Cancer Discovery, a journal of the American Association for Cancer Research, the study found that in melanoma, the deadliest form of skin cancer, cancer cells that have spread to the brain depend on amyloid beta to survive there.

Southern Spine, LLC, an ISO 13485:2016 certified manufacturer of implants and instruments for spinal surgery based in Macon, Georgia, announces that it has formed its first Center of Excellence together with Integrated Pain Associates in Killeen, Texas.